ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 41 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,000 | 0.0% | 2,365 | +29.6% | 0.00% | – |
| Q3 2016 | $5,000 | +66.7% | 1,825 | +12.4% | 0.00% | – |
| Q2 2016 | $3,000 | -70.0% | 1,624 | -94.7% | 0.00% | – |
| Q1 2016 | $10,000 | -90.0% | 30,674 | -7.7% | 0.00% | – |
| Q4 2015 | $100,000 | -90.3% | 33,226 | -71.2% | 0.00% | – |
| Q1 2015 | $1,028,000 | -25.1% | 115,282 | -0.1% | 0.00% | – |
| Q4 2014 | $1,372,000 | +25.5% | 115,451 | +17.6% | 0.00% | – |
| Q3 2014 | $1,093,000 | -18.7% | 98,153 | -3.7% | 0.00% | – |
| Q2 2014 | $1,344,000 | -25.5% | 101,961 | -8.3% | 0.00% | -100.0% |
| Q1 2014 | $1,804,000 | – | 111,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,907,008 | $21,244,000 | 14.99% |
| Third Rock Ventures, LLC | 4,841,591 | $53,935,000 | 6.29% |
| Broadfin Capital, LLC | 857,715 | $9,555,000 | 1.00% |
| NJ State Employees Deferred Compensation Plan | 25,000 | $278,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 112,485 | $1,253,000 | 0.05% |
| C WorldWide Group Holding A/S | 100,000 | $1,161,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 9,921 | $111,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 19,997 | $223,000 | 0.01% |
| Ground Swell Capital, LLC | 402 | $4,000 | 0.01% |
| Point72 Asset Management, L.P. | 55,450 | $618,000 | 0.01% |